BSH 2018: Creating off-site, nurse-led treatment units for administration of chemotherapy to people with lymphoma
The launch of biosimilar rituximab provided an opportunity to save £300,000 per year but called for time-consuming intravenous administration that exceeded the capacity of the hospital unit. Off-site… read more.